124 related articles for article (PubMed ID: 10668566)
1. Effects of hypochlorite-modified low-density and high-density lipoproteins on intracellular Ca2+ and plasma membrane Ca(2+)-ATPase activity of human platelets.
Zabe M; Feltzer RE; Malle E; Sattler W; Dean WL
Cell Calcium; 1999 Dec; 26(6):281-7. PubMed ID: 10668566
[TBL] [Abstract][Full Text] [Related]
2. Effect of hypochlorite (HOCl)-modified low density lipoproteins and high density lipoproteins on platelet function.
Opper C; Schüssler G; Sattler W; Malle E
Platelets; 1998; 9(5):339-41. PubMed ID: 16793758
[TBL] [Abstract][Full Text] [Related]
3. Oxidation by hypochlorite converts protective HDL into a potent platelet agonist.
Assinger A; Schmid W; Eder S; Schmid D; Koller E; Volf I
FEBS Lett; 2008 Mar; 582(5):778-84. PubMed ID: 18267121
[TBL] [Abstract][Full Text] [Related]
4. Interactions between lipoproteins and platelet membranes in obesity.
Raffaelli F; Nanetti L; D'Angelo M; Montecchiani G; Alidori A; Montesi L; Faloia E; Vignini A; Mazzanti L
Obesity (Silver Spring); 2009 Jul; 17(7):1375-80. PubMed ID: 19197263
[TBL] [Abstract][Full Text] [Related]
5. Presence of hypochlorite-modified proteins in human atherosclerotic lesions.
Hazell LJ; Arnold L; Flowers D; Waeg G; Malle E; Stocker R
J Clin Invest; 1996 Mar; 97(6):1535-44. PubMed ID: 8617887
[TBL] [Abstract][Full Text] [Related]
6. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
[TBL] [Abstract][Full Text] [Related]
7. Effects of oxidation on the structure and stability of human low-density lipoprotein.
Jayaraman S; Gantz DL; Gursky O
Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660
[TBL] [Abstract][Full Text] [Related]
8. Effect of hydrogen peroxide on Ca2+ mobilisation in human platelets through sulphydryl oxidation dependent and independent mechanisms.
Redondo PC; Salido GM; Rosado JA; Pariente JA
Biochem Pharmacol; 2004 Feb; 67(3):491-502. PubMed ID: 15037201
[TBL] [Abstract][Full Text] [Related]
9. Immunological evidence for hypochlorite-modified proteins in human kidney.
Malle E; Woenckhaus C; Waeg G; Esterbauer H; Gröne EF; Gröne HJ
Am J Pathol; 1997 Feb; 150(2):603-15. PubMed ID: 9033274
[TBL] [Abstract][Full Text] [Related]
10. Platelet-stimulating effects of oxidized LDL are not attributable to toxic properties of the lipoproteins.
Schmid W; Assinger A; Lee A; Bielek E; Koller E; Volf I
Thromb Res; 2008; 122(5):630-9. PubMed ID: 18387657
[TBL] [Abstract][Full Text] [Related]
11. Activated platelets contribute to oxidized low-density lipoproteins and dysfunctional high-density lipoproteins through a phospholipase A2-dependent mechanism.
Blache D; Gautier T; Tietge UJ; Lagrost L
FASEB J; 2012 Feb; 26(2):927-37. PubMed ID: 22042222
[TBL] [Abstract][Full Text] [Related]
12. Oxidized low density lipoprotein inhibits platelet plasma membrane Ca(2+)-ATPase.
Zhao B; Dierichs R; Miller FN; Dean WL
Cell Calcium; 1996 May; 19(5):453-8. PubMed ID: 8793185
[TBL] [Abstract][Full Text] [Related]
13. Endogenously generated reactive oxygen species reduce PMCA activity in platelets from patients with non-insulin-dependent diabetes mellitus.
Jardín I; Redondo PC; Salido GM; Pariente JA; Rosado JA
Platelets; 2006 Aug; 17(5):283-8. PubMed ID: 16928598
[TBL] [Abstract][Full Text] [Related]
14. [Amplification and inhibition of platelet function by serum lipoproteins].
Higashihara M
Nihon Rinsho; 1992 Feb; 50(2):282-6. PubMed ID: 1613982
[TBL] [Abstract][Full Text] [Related]
15. Plasma membrane Ca(2+)-ATPase (PMCA) translocates to filopodia during platelet activation.
Dean WL; Whiteheart SW
Thromb Haemost; 2004 Feb; 91(2):325-33. PubMed ID: 14961161
[TBL] [Abstract][Full Text] [Related]
16. Modified low-density lipoproteins and high-density lipoproteins. From investigation tools to real in vivo players.
Koller E; Volf I; Gurvitz A; Koller F
Pathophysiol Haemost Thromb; 2006; 35(3-4):322-45. PubMed ID: 16877881
[TBL] [Abstract][Full Text] [Related]
17. Plasma membrane Ca(2+) -ATPase associates with CLP36, alpha-actinin and actin in human platelets.
Bozulic LD; Malik MT; Powell DW; Nanez A; Link AJ; Ramos KS; Dean WL
Thromb Haemost; 2007 Apr; 97(4):587-97. PubMed ID: 17393022
[TBL] [Abstract][Full Text] [Related]
18. Reincorporated plasma membrane Ca2+-ATPase can mediate B-Type Ca2+ channels observed in native membrane of human red blood cells.
Pinet C; Antoine S; Filoteo AG; Penniston JT; Coulombe A
J Membr Biol; 2002 Jun; 187(3):185-201. PubMed ID: 12163977
[TBL] [Abstract][Full Text] [Related]
19. Role of Na/Ca exchange and the plasma membrane Ca2+-ATPase in beta cell function and death.
Herchuelz A; Kamagate A; Ximenes H; Van Eylen F
Ann N Y Acad Sci; 2007 Mar; 1099():456-67. PubMed ID: 17446486
[TBL] [Abstract][Full Text] [Related]
20. Effects of malondialdehyde content in low density lipoproteins on platelet adhesion.
Suttnar J; Otáhalová E; Cermák J; Dyr JE
Platelets; 2006 Mar; 17(2):92-9. PubMed ID: 16421010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
